Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

After a series of acquisitions and an activist investor’s accusation of overspending, Pfizer is exploring an opportunity to ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.

Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...

Keurig Dr Pepper brings in Drew Panayiotou to accelerate digital marketing and Andrew Springate takes a new role.

Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Pfizer's stock underperforms the S&P 500, facing patent expirations and competition, yet offers a 6.3% forward dividend yield. Despite a positive Q3 earnings surprise, profitability remains weaker ...

Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...

Havas Health has appointed Anna Maria Marra CEO of Europe. Marra is joining the healthcare agency after a 22-year run at ...

Pfizer is considering selling its hospital drugs unit, known as Pfizer Hospital, to reduce debt and streamline operations. This move follows pressure from activist investors and a history of large ...

Pfizer (NYSE:PFE) has hired Goldman Sachs to gauge initial buyer interest as part of an attempt to sell its hospital drugs ...